Abstract

Phospholipase C (PLC) hydrolyzes the phosphodiester bond of the membrane phospholipid phosphotidylinositol (4,5)‐bisphosphate (PtdIns(4,5)P2) to generate the second messengers diacylglycerol (DAG) and inositol 1,4,5‐trisphosphate (IP3). A number of PLC isoforms are present in vascular smooth muscle cells, including members of the PLCβ, PLCg, and PLCd families. Pharmacological inhibition of PLC activity blocks both pressure‐ and agonist‐induced vasoconstriction. To test the hypothesis that specific PLC isoforms influence discreet vasoconstrictor pathways, we used small interfering RNA (siRNA) to silence PLCγ1 expression in intact cerebral resistance arteries. Expression of PLCγ1 in intact cerebral arteries treated with siRNA was reduced by approximately 70% compared to controls. Arteries treated with PLCγ1 siRNA failed to constrict in response to increases in intraluminal pressure. In contrast, vasoconstriction in response to the purinergic receptor agonist uridine triphoshphate (UTP) did not differ between PLCγ1 siRNA‐treated arteries and controls. These finding demonstrate that PLCγ1 is required to regulate myogenic responsiveness, whereas other PLC isoforms regulate agonist‐induced vasoconstriction. AHA0535226N.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call